https://neurofixpharma.com/wp-content/uploads/2023/08/12-13.png
1080
1920
Juan Tostado
https://neurofixpharma.com/wp-content/uploads/2022/05/neurofix-1-2.svg
Juan Tostado2023-08-24 13:33:412023-08-24 17:40:12Neurofix Pharma will participate in the major biotechnology events.
https://neurofixpharma.com/wp-content/uploads/2022/11/neurofix-acto-salamanca02.jpeg
1045
1600
Pablo Montes
https://neurofixpharma.com/wp-content/uploads/2022/05/neurofix-1-2.svg
Pablo Montes2022-11-28 08:46:372023-07-03 10:32:38Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca
https://neurofixpharma.com/wp-content/uploads/2022/11/manueco-neurofix-scaled.jpg
1706
2560
Pablo Montes
https://neurofixpharma.com/wp-content/uploads/2022/05/neurofix-1-2.svg
Pablo Montes2022-11-11 15:42:282023-07-03 10:33:50Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial
https://neurofixpharma.com/wp-content/uploads/2022/11/equipo-neurofix.jpg
1333
2000
Pablo Montes
https://neurofixpharma.com/wp-content/uploads/2022/05/neurofix-1-2.svg
Pablo Montes2022-11-10 09:03:452023-07-03 10:34:08Neurofix Pharma enters the ‘club of the chosen ones’ by reaching the last phase of one of the most competitive EU calls.
